Showing results (11-20 of 149) with videos related to
Sort By:
Pageof 15
Immunology Letters|November 16, 2007
Dendritic cell CD83: a therapeutic target or innocent bystander?Charlene M Prazma, Thomas F TedderSpringer Seminars in Immunopathology|November 9, 2006
Fcgamma receptor-dependent effector mechanisms regulate CD19 and CD20 antibody immunotherapies for B lymphocyte malignancies and autoimmunityThomas F Tedder, Aris Baras, Yan XiuImmunology|May 3, 2007
B-lymphocyte depletion ameliorates Sjögren's syndrome in Id3 knockout miceIkuko Hayakawa, Thomas F Tedder, Yuan ZhuangArthritis Research & Therapy|April 10, 2013
IL-10-producing regulatory B cells (B10 cells) in autoimmune diseaseIoannis Kalampokis, Ayumi Yoshizaki, Thomas F TedderAnnals of the New York Academy of Sciences|February 12, 2010
B10 cells and regulatory B cells balance immune responses during inflammation, autoimmunity, and cancerDavid J DiLillo, Takashi Matsushita, Thomas F TedderImmunologic Research|December 3, 2010
B-lymphocyte effector functions in health and diseaseDavid J DiLillo, Mayuka Horikawa, Thomas F TedderImmunological Reviews|September 2, 2008
Regulatory B cells as inhibitors of immune responses and inflammationJean-David Bouaziz, Koichi Yanaba, Thomas F TedderJournal of Immunology (Baltimore, Md. : 1950)|March 3, 2010
B cells are required for optimal CD4+ and CD8+ T cell tumor immunity: therapeutic B cell depletion enhances B16 melanoma growth in miceDavid J DiLillo, Koichi Yanaba, Thomas F TedderCurrent Protocols in Immunology|November 7, 2012
Isolation and generation of human dendritic cellsSmita Nair, Gerald E Archer, Thomas F TedderInternational Immunology|August 9, 2015
Regulatory B10 cell development and functionJacquelyn M Lykken, Kathleen M Candando, Thomas F TedderPageof 15